Delivery Order SPE2DB25D3021-SPE2DB25FQYVR
Award Date
6/24/25
Potential Completion Date
6/25/25
Potential Value
$7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $10,094.56 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 18, 2025, with a completion date of April 21, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceuticals, with an ultimate completion date of December 11, 2024. The $100,402.15 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a delivery order and is not associated with a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceuticals to the Defense Logistics Agency (DLA). The $7,046.64 delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a performance period through September 23, 2022 and is a firm fixed-price delivery order. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, to the U.S. government. The contract, valued at $17,734.34, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Medical Supply Chain division of the Defense agency. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the Defense Logistics Agency (DLA) Troop Support Medical, valued up...
This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL pharmaceutical products to the Defense Logistics Agency (DLA). The $5,486.46 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceuticals and medical supplies to the U.S. government. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS to the Defense Logistics Agency (DLA), a defense agency. The $13,728.70 firm fixed price delivery order has a completion date of May 21, 2025 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 20, 2025. The contract is not set aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS to the Medical Supply Chain, a subcomponent of the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $43,318.16. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of July 3, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
The federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,454.37 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with an ultimate completion date of September 6, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, for the supply of a comprehensive range...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a potential value of $7,859.70 and a performance period ending on February 8, 2024. No set-aside...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $14,592.15 and an ultimate completion date of December 24, 2024. This appears to be a delivery order against a larger Indefinite Delivery Contract (IDC) that...